1. Home
  2. USAS vs LUNG Comparison

USAS vs LUNG Comparison

Compare USAS & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USAS
  • LUNG
  • Stock Information
  • Founded
  • USAS 1998
  • LUNG 1995
  • Country
  • USAS Canada
  • LUNG United States
  • Employees
  • USAS N/A
  • LUNG N/A
  • Industry
  • USAS Metal Mining
  • LUNG Industrial Specialties
  • Sector
  • USAS Basic Materials
  • LUNG Health Care
  • Exchange
  • USAS Nasdaq
  • LUNG Nasdaq
  • Market Cap
  • USAS 536.1M
  • LUNG 124.0M
  • IPO Year
  • USAS N/A
  • LUNG 2020
  • Fundamental
  • Price
  • USAS $0.84
  • LUNG $2.78
  • Analyst Decision
  • USAS Strong Buy
  • LUNG Buy
  • Analyst Count
  • USAS 1
  • LUNG 6
  • Target Price
  • USAS $1.00
  • LUNG $11.53
  • AVG Volume (30 Days)
  • USAS 1.8M
  • LUNG 311.3K
  • Earning Date
  • USAS 08-14-2025
  • LUNG 07-30-2025
  • Dividend Yield
  • USAS N/A
  • LUNG N/A
  • EPS Growth
  • USAS N/A
  • LUNG N/A
  • EPS
  • USAS N/A
  • LUNG N/A
  • Revenue
  • USAS $102,883,000.00
  • LUNG $87,473,000.00
  • Revenue This Year
  • USAS $45.78
  • LUNG $18.02
  • Revenue Next Year
  • USAS $17.98
  • LUNG $18.17
  • P/E Ratio
  • USAS N/A
  • LUNG N/A
  • Revenue Growth
  • USAS 8.12
  • LUNG 19.84
  • 52 Week Low
  • USAS $0.21
  • LUNG $2.50
  • 52 Week High
  • USAS $0.90
  • LUNG $9.37
  • Technical
  • Relative Strength Index (RSI)
  • USAS 66.28
  • LUNG 41.83
  • Support Level
  • USAS $0.80
  • LUNG $2.52
  • Resistance Level
  • USAS $0.90
  • LUNG $2.84
  • Average True Range (ATR)
  • USAS 0.05
  • LUNG 0.16
  • MACD
  • USAS -0.00
  • LUNG 0.04
  • Stochastic Oscillator
  • USAS 88.89
  • LUNG 46.36

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: